The PE Ratio as of December 2025 (TTM) for Swedish Orphan Biovitrum AB (publ) (BIOVF) is 26.50

According to Swedish Orphan Biovitrum AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is 26.50. This represents a change of 35.72% compared to the average of 19.53 of the last 4 quarters.

Swedish Orphan Biovitrum AB (publ) (BIOVF) Historical PE Ratio (quarterly & annually)

How has BIOVF PE Ratio performed in the past?

The mean historical PE Ratio of Swedish Orphan Biovitrum AB (publ) over the last ten years is 75.06. The current 26.50 PE Ratio has changed 3.43% with respect to the historical average. Over the past ten years (40 quarters), BIOVF's PE Ratio was at its highest in in the September 2023 quarter at 187.71. The PE Ratio was at its lowest in in the December 2015 quarter at -1046.09.

Swedish Orphan Biovitrum AB (publ) (BIOVF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Swedish Orphan Biovitrum AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Swedish Orphan Biovitrum AB (publ) (BIOVF) Average PE Ratio

How has BIOVF PE Ratio performed in the past?

The current PE Ratio of Swedish Orphan Biovitrum AB (publ) (BIOVF) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Swedish Orphan Biovitrum AB (publ) (BIOVF) PE Ratio vs. Peers

How is BIOVF’s PE Ratio compared to its peers?

Swedish Orphan Biovitrum AB (publ)’s PE Ratio is greater than Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (21.82), greater than CSPC Pharmaceutical Group Limited (18.61), greater than Orion Oyj (22.62), greater than Recordati Industria Chimica e Farmaceutica S.p.A. (24.88), less than Eisai Co., Ltd. (26.65), less than Eisai Co., Ltd. (26.65), greater than CSPC Pharmaceutical Group Limited (18.61), less than Eurofins Scientific SE (40.58), greater than Bangkok Dusit Medical Services Public Company Limited (18.20), greater than Grifols, S.A. (24.98),

Build a custom stock screener for Swedish Orphan Biovitrum AB (publ) (BIOVF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Swedish Orphan Biovitrum AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Swedish Orphan Biovitrum AB (publ) (BIOVF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Swedish Orphan Biovitrum AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.